Medicina, Italy

Eleonora Romagnoli


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Eleonora Romagnoli in Atherosclerosis Treatment

Introduction: Eleonora Romagnoli, a prominent inventor residing in Medicina, Italy, has made significant strides in the field of pharmacology. With a focus on enhancing health outcomes through innovative substances, she has secured her position as a key contributor to medical advancements.

Latest Patents: Eleonora holds a patent for "Lactones with antioxidising and hypolipidaemic activity useful in the treatment of atherosclerosis." This invention focuses on lactones endowed with antioxidizing properties that are capable of preventing or delaying oxidative modifications of lipoproteins, specifically by scavenging peroxylic radicals. The compounds derived from this patent are intended for treating atherosclerosis and associated vascular diseases, effectively addressing conditions such as ischaemic cardiopathies, cerebral thrombosis, and peripheral arteriopathies.

Career Highlights: Working at Alfa Wassermann S.p.a., Eleonora has dedicated her career to researching and developing innovative solutions that target critical aspects of cardiovascular health. Her innovative research has culminated in the patent that highlights her commitment to addressing significant health issues related to lipid levels and oxidative stress.

Collaborations: Throughout her career, Eleonora has collaborated with esteemed colleagues Goffredo Rosini and Claudia Baldazzi, whose combined expertise has helped propel research initiatives forward. These collaborations have not only enhanced the quality of their research but have also paved the way for impactful innovations in the pharmaceutical field.

Conclusion: Eleonora Romagnoli stands out as a significant figure in the world of inventors, particularly with her groundbreaking work in developing compounds that can change the course of treatment for atherosclerosis and related conditions. Her dedication to innovation and collaboration continues to inspire progress in medical research and pharmacology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…